Skip to content

The Impact of Virtual Reality on the Emotional State of Patients With Aphasia During Rehabilitation.

The Impact of Virtual Reality on the Emotional State of Patients With Aphasia During Rehabilitation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04533308
Enrollment
40
Registered
2020-08-31
Start date
2020-08-20
Completion date
2022-08-01
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Emotional Disturbances, Virtual Reality

Brief summary

The aim of the study is to determine virtual reality (VR) impact during standard program of rehabilitation on emotional state of patients with aphasia.

Detailed description

Aim 1: To test the safety of virtual reality in a vulnerable population of patients with aphasia during rehabilitation. Participants will be alternately assigned to receiving a relaxation session in VR every working day during a standard course of rehabilitation. Aim 2: To test the preliminary efficacy of combining VR with the course of rehabilitation to promote emotional improvements in patients with aphasia.

Interventions

BEHAVIORALRelaxation in virtual reality

Natural 360-degrees scenes from different locations in the world with or without interactions with animals in the virtual reality

Sponsors

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Mild or moderate aphasia of any type * Russian is primary language * At least 2 weeks post cardio-vascular accident (ischemic or hemorrhagic stroke) or head injury of any location * Have a history of only one stroke * Medically stable

Exclusion criteria

* Associated severe cognitive deficits and psychiatric disorders which prevent patients understanding of the informed consent * Epilepsy * Medical history of severe visual or hearing impairment * Comorbid neurological diagnosis (e.g. epilepsy, multiple sclerosis, Parkinson disease, dementia) * Unable to perform the required exercises due to severe motor, sensory or cognitive deficit (memory, attention, executive functioning, apraxia, regulatory and planning activities etc.) and medical problems (for example, anyone meeting New York Heart Association Class IV criteria, hospitalization for myocardial infarction or heart surgery within 120 days, severe cardiomyopathy or documented serious and unstable cardiac arrhythmias) * Drug or alcohol addiction within the last 6 months. * Significant current psychiatric illness defined as affective disorder unresponsive to medication or bipolar affective disorder, psychosis, schizophrenia or suicidality * Current participation in another interventional trial

Design outcomes

Primary

MeasureTime frameDescription
The absence of severe adverse reactionsFrom admission to discharge, up to 3 weeksAssessed by a self-reported form and physiological parameters

Secondary

MeasureTime frameDescription
10 - Stroke Aphasic Depression Questionnaire (SADQH-10)From admission to discharge, up to 3 weeksScores range from 0 to 30 with lower scores denoting better outcomes.
Visual Analog Mood Scale (VAMS)From admission to discharge, up to 3 weeksScores range from 0 to 10 with lower scores denoting better outcomes.
Lüscher Color TestFrom admission to discharge, up to 3 weeksEight different colored cards are place in order of preference. The descriptive statements formed by Lüscher for each color were used to interpret the results.
Three-level European quality of life five-dimensional questionnaireFrom admission to discharge, up to 3 weeksThere are five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. Patients choice results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describe the health status.
Aphasic Depression Rating Scale (ADRS)From admission to discharge, up to 3 weeksScores range from 0 to 36 with lower scores denoting better outcomes.
Perceived Stress Scale (PSS)From admission to discharge, up to 3 weeksScores range from 0 to 50 with lower scores denoting better outcomes.

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026